HK1110224A1 - Therapeutic agent for cancer - Google Patents

Therapeutic agent for cancer

Info

Publication number
HK1110224A1
HK1110224A1 HK08104563.1A HK08104563A HK1110224A1 HK 1110224 A1 HK1110224 A1 HK 1110224A1 HK 08104563 A HK08104563 A HK 08104563A HK 1110224 A1 HK1110224 A1 HK 1110224A1
Authority
HK
Hong Kong
Prior art keywords
cancer
therapeutic agent
therapeutic
agent
Prior art date
Application number
HK08104563.1A
Other languages
English (en)
Inventor
Eisuke Mekada
Shingo Miyamoto
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of HK1110224A1 publication Critical patent/HK1110224A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK08104563.1A 2005-06-21 2008-04-24 Therapeutic agent for cancer HK1110224A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005181314 2005-06-21
JP2006027581 2006-02-03
PCT/JP2006/312321 WO2006137398A1 (ja) 2005-06-21 2006-06-20 癌治療薬

Publications (1)

Publication Number Publication Date
HK1110224A1 true HK1110224A1 (en) 2008-07-11

Family

ID=37570427

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08104563.1A HK1110224A1 (en) 2005-06-21 2008-04-24 Therapeutic agent for cancer

Country Status (9)

Country Link
US (1) US7700546B2 (xx)
EP (1) EP1894575B1 (xx)
JP (1) JP5052338B2 (xx)
KR (1) KR101052090B1 (xx)
CN (1) CN101208106B (xx)
AU (1) AU2006260240B2 (xx)
CA (1) CA2610281C (xx)
HK (1) HK1110224A1 (xx)
WO (1) WO2006137398A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5110980B2 (ja) * 2007-06-26 2012-12-26 一般財団法人阪大微生物病研究会 肺がん治療薬
FR2988393B1 (fr) 2012-03-20 2014-05-09 Commissariat Energie Atomique Inhibiteur de l'hb-egf derive du domaine r de la toxine diphterique pour le traitement des maladies associees a l'activation de la voie hb-egf/egfr
JP5987175B2 (ja) * 2012-07-02 2016-09-07 学校法人福岡大学 乳癌,胃癌及び卵巣癌等に対する制癌剤
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
CN109790545A (zh) * 2016-03-10 2019-05-21 约翰·霍普金斯大学 产生不含聚集物的单体白喉毒素融合蛋白的方法和治疗用途
US20200331973A1 (en) * 2017-09-01 2020-10-22 Lorven Biologics Private Limited Nucleic acid encoding crm197 and process for improved expression thereof
CA3104833A1 (en) 2018-07-16 2020-01-23 Dcprime B.V. A combination product for use in tumor vaccination.
AU2020264083A1 (en) 2019-04-25 2021-12-02 Mendus B.V. Methods of tumor vaccination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4203742B2 (ja) 2002-10-15 2009-01-07 財団法人阪大微生物病研究会 制癌剤

Also Published As

Publication number Publication date
JPWO2006137398A1 (ja) 2009-01-22
WO2006137398A1 (ja) 2006-12-28
AU2006260240B2 (en) 2012-03-15
CN101208106B (zh) 2011-07-27
US20090105135A1 (en) 2009-04-23
EP1894575B1 (en) 2013-02-20
AU2006260240A1 (en) 2006-12-28
CN101208106A (zh) 2008-06-25
CA2610281A1 (en) 2006-12-28
KR101052090B1 (ko) 2011-07-27
EP1894575A4 (en) 2010-02-24
KR20080017093A (ko) 2008-02-25
CA2610281C (en) 2014-07-29
JP5052338B2 (ja) 2012-10-17
US7700546B2 (en) 2010-04-20
EP1894575A1 (en) 2008-03-05

Similar Documents

Publication Publication Date Title
EP1967209A4 (en) THERAPEUTIC AGENT AGAINST PROSTATE CANCER
EP1876186A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER
IL190882A0 (en) Compositions for cancer therapy
IL185908A0 (en) Therapeutic agent for dyskinesia
SI3424932T1 (sl) Boronoftalidi za terapevtsko uporabo
GB0521139D0 (en) Therapeutic agent
EP2127671A4 (en) THERAPEUTIC AGENT AGAINST CANCER
GB0516091D0 (en) Therapeutic agent
GB0506147D0 (en) Therapeutic agents
IL197389A0 (en) Prophylactic or therapeutic agent for cancer
EP1797903A4 (en) DIAGNOSTIC AGENT FOR TUMOR
GB0505725D0 (en) Therapeutic agents
GB0505437D0 (en) Therapeutic agents
PT1830847E (pt) Tratamento para o cancro
HK1110224A1 (en) Therapeutic agent for cancer
EP2018873A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER
EP1923072A4 (en) MEDICINE FOR PROPHYLAXIS / TREATMENT OF CANCER
EP1974732A4 (en) THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
EP1908467A4 (en) HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN
GB0508153D0 (en) Therapeutic agent
EP1900363A4 (en) THERAPEUTIC AGENT AGAINST PAIN
GB0507685D0 (en) Cancer treatment
EP1876447A4 (en) MEANS OF TUMOR DIAGNOSIS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170620